D

Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192

Watchlist Manager
Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192
Watchlist
Price: 42.31 CNY -1.21% Market Closed
Market Cap: 17.6B CNY
Have any thoughts about
Dizal Jiangsu Pharmaceutical Co Ltd?
Write Note

Income Statement

Earnings Waterfall
Dizal Jiangsu Pharmaceutical Co Ltd

Revenue
172.6m CNY
Cost of Revenue
-6.2m CNY
Gross Profit
166.4m CNY
Operating Expenses
-1.3B CNY
Operating Income
-1.1B CNY
Other Expenses
10.7m CNY
Net Income
-1.1B CNY

Income Statement
Dizal Jiangsu Pharmaceutical Co Ltd

Rotate your device to view
Income Statement
Currency: CNY
Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024
Revenue
Revenue
10
N/A
7
-30%
4
-49%
0
N/A
0
N/A
0
N/A
40
N/A
91
+128%
173
+89%
Gross Profit
Cost of Revenue
(9)
(6)
(3)
0
(0)
(1)
(2)
(3)
(6)
Gross Profit
1
N/A
1
-37%
0
-69%
0
N/A
(0)
N/A
(1)
-20%
38
N/A
88
+134%
166
+89%
Operating Income
Operating Expenses
(720)
(744)
(755)
(786)
(839)
(939)
(1 116)
(1 213)
(1 270)
Selling, General & Administrative
(90)
(94)
(106)
(119)
(197)
(274)
(364)
(427)
(471)
Research & Development
(613)
(636)
(649)
(612)
(653)
(678)
(763)
(745)
(854)
Depreciation & Amortization
0
0
0
(63)
0
0
0
(73)
0
Other Operating Expenses
(16)
(14)
(0)
7
11
13
12
32
56
Operating Income
(718)
N/A
(743)
-3%
(755)
-2%
(786)
-4%
(840)
-7%
(940)
-12%
(1 078)
-15%
(1 125)
-4%
(1 103)
+2%
Pre-Tax Income
Interest Income Expense
2
28
42
50
46
34
23
17
11
Non-Reccuring Items
0
0
0
0
0
0
(0)
(0)
0
Pre-Tax Income
(716)
N/A
(716)
+0%
(713)
+0%
(736)
-3%
(794)
-8%
(905)
-14%
(1 055)
-17%
(1 108)
-5%
(1 092)
+1%
Net Income
Tax Provision
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
Income from Continuing Operations
(716)
(716)
(714)
(736)
(794)
(905)
(1 055)
(1 108)
(1 092)
Net Income (Common)
(716)
N/A
(716)
0%
(714)
+0%
(736)
-3%
(794)
-8%
(905)
-14%
(1 055)
-17%
(1 108)
-5%
(1 092)
+1%
EPS (Diluted)
-1.77
N/A
-1.78
-1%
-1.77
+1%
-1.82
-3%
-1.96
-8%
-2.23
-14%
-2.59
-16%
-2.72
-5%
-2.63
+3%

See Also

Discover More